Pharmacovigilance is defined by the World Health Organization (WHO) as:
The science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.
The main objectives of pharmacovigilance in accordance with the applicable EU legislation are:
- Preventing harm from adverse reactions in humans.
- Promoting the safe and effective use of medicinal products, in particular by providing timely information about the safety of medicinal products for patients, healthcare professionals and the public.
Pharmacovigilance is therefore an activity contributing to the protection of patient and public health.
National Organization for Medicines
Contact details for Pharmacovigilance of Chiesi Hellas: